Teichmann Sarah A.
SEC insider (Form 3/4/5 filer). CIK 0002030916. Director at 10x Genomics, Inc. (TXG). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in PLEASANTON, CA.
Companies Teichmann Sarah A. has filed insider reports for
- 10x Genomics, Inc. (TXG): Director
Teichmann Sarah A.
CIK: 0002030916
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TXG
10x Genomics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 14, 2026TXG
10x Genomics, Inc.
SaleDirect2.3K shares at avg. $57.15$130K - Aug 13, 2026TXG
10x Genomics, Inc.
SaleDirect5.3K shares at avg. $57.29$302K - Jun 4, 2026TXG
10x Genomics, Inc.
AwardDirect8.8K shares- - Feb 25, 2026TXG
10x Genomics, Inc.
SaleDirect7.6K shares at avg. $19.41$147K - Jun 3, 2025TXG
10x Genomics, Inc.
AwardDirect15.4K shares- - Aug 30, 2024TXG
10x Genomics, Inc.
AwardDirect19K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 | TXG 10x Genomics, Inc. | Sale | 2,273 | $57.15 | $129,902 | Direct |
| Aug 13, 2026 | TXG 10x Genomics, Inc. | Sale | 5,278 | $57.29 | $302,377 | Direct |
| Jun 4, 2026 | TXG 10x Genomics, Inc. | Award | 8,829 | - | $0 | Direct |
| Feb 25, 2026 | TXG 10x Genomics, Inc. | Sale | 7,579 | $19.41 | $147,108 | Direct |
| Jun 3, 2025 | TXG 10x Genomics, Inc. | Award | 15,357 | - | - | Direct |
| Aug 30, 2024 | TXG 10x Genomics, Inc. | Award | 19,002 | - | $0 | Direct |
1-6 of 6 transactions